Vestal Point Capital, LP Exact Sciences Corp Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Vestal Point Capital, LP holds 925,000 shares of EXAS stock, worth $61 Million. This represents 2.91% of its overall portfolio holdings.
Number of Shares
925,000
Previous 100,000
825.0%
Holding current value
$61 Million
Previous $6.91 Billion
465.9%
% of portfolio
2.91%
Previous 0.57%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.2 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.09 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$975 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$796 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$542 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...